Search
Now showing items 1-1 of 1
Inhibition of Metabolic Enzymes as Differentiation Therapy in Acute Myeloid Leukemia
(2017-01-26)
Acute myeloid leukemia (AML) is among the deadliest of cancers: it carries a 27% 5-year survival rate and is responsible for over 10,000 deaths annually in the United States alone. Despite the clear medical need, new ...